nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—Topoisomerase Inhibitors—Doxorubicin—kidney cancer	0.317	1	CiPCiCtD
Irinotecan—pancreatic cancer—kidney cancer	0.132	0.553	CtDrD
Irinotecan—lung cancer—kidney cancer	0.107	0.447	CtDrD
Irinotecan—ACHE—kidney cancer	0.0815	0.55	CbGaD
Irinotecan—BCHE—kidney cancer	0.0479	0.323	CbGaD
Irinotecan—CES1—Capecitabine—kidney cancer	0.0191	0.0948	CbGbCtD
Irinotecan—ABCB1—kidney cancer	0.0188	0.127	CbGaD
Irinotecan—UGT1A1—Pazopanib—kidney cancer	0.00909	0.0451	CbGbCtD
Irinotecan—CYP3A7—Temsirolimus—kidney cancer	0.00703	0.0349	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.00703	0.0349	CbGbCtD
Irinotecan—ABCC1—Dactinomycin—kidney cancer	0.00684	0.0339	CbGbCtD
Irinotecan—UGT1A1—Erlotinib—kidney cancer	0.00649	0.0322	CbGbCtD
Irinotecan—UGT1A9—Sorafenib—kidney cancer	0.00645	0.032	CbGbCtD
Irinotecan—SLC22A3—Vincristine—kidney cancer	0.00645	0.032	CbGbCtD
Irinotecan—SLCO1B1—Pazopanib—kidney cancer	0.0063	0.0312	CbGbCtD
Irinotecan—UGT1A1—Sorafenib—kidney cancer	0.00528	0.0262	CbGbCtD
Irinotecan—CYP3A5—Temsirolimus—kidney cancer	0.00528	0.0262	CbGbCtD
Irinotecan—ABCG2—Pazopanib—kidney cancer	0.005	0.0248	CbGbCtD
Irinotecan—ABCC1—Paclitaxel—kidney cancer	0.00488	0.0242	CbGbCtD
Irinotecan—ABCG2—Dactinomycin—kidney cancer	0.00457	0.0227	CbGbCtD
Irinotecan—ABCC1—Vinblastine—kidney cancer	0.00428	0.0212	CbGbCtD
Irinotecan—ABCC1—Vincristine—kidney cancer	0.00421	0.0209	CbGbCtD
Irinotecan—ABCC2—Paclitaxel—kidney cancer	0.00361	0.0179	CbGbCtD
Irinotecan—ABCG2—Erlotinib—kidney cancer	0.00357	0.0177	CbGbCtD
Irinotecan—ABCB1—Temsirolimus—kidney cancer	0.00343	0.017	CbGbCtD
Irinotecan—ABCG2—Paclitaxel—kidney cancer	0.00327	0.0162	CbGbCtD
Irinotecan—ABCC2—Sorafenib—kidney cancer	0.00321	0.0159	CbGbCtD
Irinotecan—ABCC2—Vinblastine—kidney cancer	0.00317	0.0157	CbGbCtD
Irinotecan—ABCC2—Vincristine—kidney cancer	0.00312	0.0155	CbGbCtD
Irinotecan—CYP3A4—Everolimus—kidney cancer	0.00305	0.0151	CbGbCtD
Irinotecan—ABCG2—Sorafenib—kidney cancer	0.0029	0.0144	CbGbCtD
Irinotecan—ABCG2—Vincristine—kidney cancer	0.00282	0.014	CbGbCtD
Irinotecan—ABCC1—Doxorubicin—kidney cancer	0.00263	0.013	CbGbCtD
Irinotecan—ABCC2—Sunitinib—kidney cancer	0.0026	0.0129	CbGbCtD
Irinotecan—ALB—Erlotinib—kidney cancer	0.00246	0.0122	CbGbCtD
Irinotecan—CYP3A7—Paclitaxel—kidney cancer	0.00241	0.012	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.00241	0.012	CbGbCtD
Irinotecan—ABCG2—Sunitinib—kidney cancer	0.00235	0.0117	CbGbCtD
Irinotecan—CYP3A7—Sorafenib—kidney cancer	0.00214	0.0106	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.00214	0.0106	CbGbCtD
Irinotecan—CYP3A7—Vincristine—kidney cancer	0.00208	0.0103	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.00208	0.0103	CbGbCtD
Irinotecan—CYP3A4—Temsirolimus—kidney cancer	0.00206	0.0102	CbGbCtD
Irinotecan—CYP2B6—Sorafenib—kidney cancer	0.00204	0.0101	CbGbCtD
Irinotecan—CYP3A5—Erlotinib—kidney cancer	0.00198	0.00981	CbGbCtD
Irinotecan—ABCC2—Doxorubicin—kidney cancer	0.00195	0.00966	CbGbCtD
Irinotecan—CYP3A5—Paclitaxel—kidney cancer	0.00181	0.00898	CbGbCtD
Irinotecan—ABCB1—Pazopanib—kidney cancer	0.0018	0.00894	CbGbCtD
Irinotecan—ABCG2—Doxorubicin—kidney cancer	0.00176	0.00873	CbGbCtD
Irinotecan—CYP3A7—Sunitinib—kidney cancer	0.00174	0.00861	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00174	0.00861	CbGbCtD
Irinotecan—ABCB1—Dactinomycin—kidney cancer	0.00165	0.00818	CbGbCtD
Irinotecan—CYP3A5—Sorafenib—kidney cancer	0.00161	0.00797	CbGbCtD
Irinotecan—CYP3A5—Vincristine—kidney cancer	0.00156	0.00774	CbGbCtD
Irinotecan—ABCB1—Gemcitabine—kidney cancer	0.0013	0.00647	CbGbCtD
Irinotecan—CYP3A5—Sunitinib—kidney cancer	0.0013	0.00646	CbGbCtD
Irinotecan—ABCB1—Erlotinib—kidney cancer	0.00129	0.00638	CbGbCtD
Irinotecan—CYP2B6—Doxorubicin—kidney cancer	0.00124	0.00614	CbGbCtD
Irinotecan—UGT1A1—urine—kidney cancer	0.00121	0.105	CbGeAlD
Irinotecan—ABCB1—Paclitaxel—kidney cancer	0.00118	0.00584	CbGbCtD
Irinotecan—CYP3A4—Pazopanib—kidney cancer	0.00108	0.00536	CbGbCtD
Irinotecan—ABCB1—Sorafenib—kidney cancer	0.00105	0.00519	CbGbCtD
Irinotecan—ABCB1—Vinblastine—kidney cancer	0.00103	0.00512	CbGbCtD
Irinotecan—ABCB1—Vincristine—kidney cancer	0.00102	0.00504	CbGbCtD
Irinotecan—ABCB1—Sunitinib—kidney cancer	0.000848	0.0042	CbGbCtD
Irinotecan—CYP3A4—Erlotinib—kidney cancer	0.000771	0.00382	CbGbCtD
Irinotecan—CYP3A4—Paclitaxel—kidney cancer	0.000706	0.0035	CbGbCtD
Irinotecan—TOP1MT—gonad—kidney cancer	0.00065	0.0567	CbGeAlD
Irinotecan—ABCB1—Doxorubicin—kidney cancer	0.000635	0.00315	CbGbCtD
Irinotecan—CYP3A4—Sorafenib—kidney cancer	0.000627	0.00311	CbGbCtD
Irinotecan—CYP3A4—Vinblastine—kidney cancer	0.000619	0.00307	CbGbCtD
Irinotecan—CYP3A4—Vincristine—kidney cancer	0.000609	0.00302	CbGbCtD
Irinotecan—CYP3A4—Sunitinib—kidney cancer	0.000508	0.00252	CbGbCtD
Irinotecan—UGT1A9—renal system—kidney cancer	0.000431	0.0375	CbGeAlD
Irinotecan—TOP1—nephron tubule—kidney cancer	0.000421	0.0367	CbGeAlD
Irinotecan—UGT1A9—kidney—kidney cancer	0.000416	0.0363	CbGeAlD
Irinotecan—Topotecan—ABCB1—kidney cancer	0.000408	1	CrCbGaD
Irinotecan—CYP3A4—urine—kidney cancer	0.000386	0.0337	CbGeAlD
Irinotecan—CES2—nephron tubule—kidney cancer	0.000382	0.0333	CbGeAlD
Irinotecan—CYP3A4—Doxorubicin—kidney cancer	0.00038	0.00189	CbGbCtD
Irinotecan—TOP1—cortex of kidney—kidney cancer	0.00036	0.0314	CbGeAlD
Irinotecan—CES2—renal system—kidney cancer	0.000347	0.0303	CbGeAlD
Irinotecan—TOP1—cardiac atrium—kidney cancer	0.000343	0.0299	CbGeAlD
Irinotecan—CES2—kidney—kidney cancer	0.000335	0.0292	CbGeAlD
Irinotecan—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000335	0.0292	CbGeAlD
Irinotecan—CES2—cortex of kidney—kidney cancer	0.000327	0.0285	CbGeAlD
Irinotecan—CES2—gonad—kidney cancer	0.000311	0.0271	CbGeAlD
Irinotecan—CES2—cardiac atrium—kidney cancer	0.000311	0.0271	CbGeAlD
Irinotecan—UGT1A1—renal system—kidney cancer	0.000295	0.0257	CbGeAlD
Irinotecan—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000287	0.025	CbGeAlD
Irinotecan—UGT1A1—kidney—kidney cancer	0.000285	0.0249	CbGeAlD
Irinotecan—SLCO1B1—renal system—kidney cancer	0.000246	0.0214	CbGeAlD
Irinotecan—SLCO1B1—kidney—kidney cancer	0.000237	0.0207	CbGeAlD
Irinotecan—ABCC2—nephron tubule—kidney cancer	0.000205	0.0179	CbGeAlD
Irinotecan—SLC22A3—renal system—kidney cancer	0.000198	0.0173	CbGeAlD
Irinotecan—SLC22A3—kidney—kidney cancer	0.000192	0.0167	CbGeAlD
Irinotecan—ABCC2—renal system—kidney cancer	0.000186	0.0162	CbGeAlD
Irinotecan—ABCC2—kidney—kidney cancer	0.00018	0.0157	CbGeAlD
Irinotecan—SLC22A3—gonad—kidney cancer	0.000178	0.0155	CbGeAlD
Irinotecan—ABCC2—cortex of kidney—kidney cancer	0.000175	0.0153	CbGeAlD
Irinotecan—BCHE—nephron tubule—kidney cancer	0.000155	0.0135	CbGeAlD
Irinotecan—ABCC1—cortex of kidney—kidney cancer	0.000154	0.0135	CbGeAlD
Irinotecan—ABCG2—nephron tubule—kidney cancer	0.000149	0.013	CbGeAlD
Irinotecan—ABCC1—cardiac atrium—kidney cancer	0.000147	0.0128	CbGeAlD
Irinotecan—CYP3A5—nephron tubule—kidney cancer	0.000139	0.0121	CbGeAlD
Irinotecan—CYP2B6—nephron tubule—kidney cancer	0.000138	0.012	CbGeAlD
Irinotecan—CYP3A5—renal system—kidney cancer	0.000126	0.011	CbGeAlD
Irinotecan—BCHE—cardiac atrium—kidney cancer	0.000126	0.011	CbGeAlD
Irinotecan—CYP2B6—renal system—kidney cancer	0.000125	0.0109	CbGeAlD
Irinotecan—CYP3A5—kidney—kidney cancer	0.000122	0.0106	CbGeAlD
Irinotecan—CYP2B6—kidney—kidney cancer	0.000121	0.0106	CbGeAlD
Irinotecan—CYP3A5—cortex of kidney—kidney cancer	0.000119	0.0103	CbGeAlD
Irinotecan—CYP2B6—gonad—kidney cancer	0.000112	0.00979	CbGeAlD
Irinotecan—CYP3A4—renal system—kidney cancer	9.46e-05	0.00824	CbGeAlD
Irinotecan—CYP3A4—kidney—kidney cancer	9.14e-05	0.00797	CbGeAlD
Irinotecan—ABCB1—nephron tubule—kidney cancer	7.36e-05	0.00642	CbGeAlD
Irinotecan—ABCB1—renal system—kidney cancer	6.69e-05	0.00584	CbGeAlD
Irinotecan—ABCB1—kidney—kidney cancer	6.47e-05	0.00564	CbGeAlD
Irinotecan—ABCB1—cortex of kidney—kidney cancer	6.3e-05	0.00549	CbGeAlD
Irinotecan—ABCB1—gonad—kidney cancer	6e-05	0.00523	CbGeAlD
Irinotecan—Renal impairment—Doxorubicin—kidney cancer	2.3e-05	0.000391	CcSEcCtD
Irinotecan—Paraesthesia—Vincristine—kidney cancer	2.3e-05	0.000391	CcSEcCtD
Irinotecan—Rash—Everolimus—kidney cancer	2.28e-05	0.000389	CcSEcCtD
Irinotecan—Dermatitis—Everolimus—kidney cancer	2.28e-05	0.000389	CcSEcCtD
Irinotecan—Headache—Vinblastine—kidney cancer	2.28e-05	0.000388	CcSEcCtD
Irinotecan—Headache—Everolimus—kidney cancer	2.27e-05	0.000386	CcSEcCtD
Irinotecan—Hypotension—Gemcitabine—kidney cancer	2.27e-05	0.000386	CcSEcCtD
Irinotecan—Abdominal pain—Dactinomycin—kidney cancer	2.26e-05	0.000386	CcSEcCtD
Irinotecan—Body temperature increased—Dactinomycin—kidney cancer	2.26e-05	0.000386	CcSEcCtD
Irinotecan—Visual impairment—Capecitabine—kidney cancer	2.26e-05	0.000385	CcSEcCtD
Irinotecan—Anaphylactoid reaction—Doxorubicin—kidney cancer	2.26e-05	0.000385	CcSEcCtD
Irinotecan—Asthenia—Sorafenib—kidney cancer	2.26e-05	0.000384	CcSEcCtD
Irinotecan—Malaise—Paclitaxel—kidney cancer	2.25e-05	0.000382	CcSEcCtD
Irinotecan—Vertigo—Paclitaxel—kidney cancer	2.24e-05	0.000381	CcSEcCtD
Irinotecan—Syncope—Paclitaxel—kidney cancer	2.23e-05	0.00038	CcSEcCtD
Irinotecan—Cerebrovascular accident—Doxorubicin—kidney cancer	2.23e-05	0.00038	CcSEcCtD
Irinotecan—Leukopenia—Paclitaxel—kidney cancer	2.23e-05	0.00038	CcSEcCtD
Irinotecan—Hypersensitivity—Sunitinib—kidney cancer	2.23e-05	0.00038	CcSEcCtD
Irinotecan—Decreased appetite—Vincristine—kidney cancer	2.22e-05	0.000379	CcSEcCtD
Irinotecan—Vomiting—Erlotinib—kidney cancer	2.22e-05	0.000378	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Vincristine—kidney cancer	2.21e-05	0.000376	CcSEcCtD
Irinotecan—Fatigue—Vincristine—kidney cancer	2.21e-05	0.000376	CcSEcCtD
Irinotecan—Rash—Erlotinib—kidney cancer	2.2e-05	0.000375	CcSEcCtD
Irinotecan—Dermatitis—Erlotinib—kidney cancer	2.2e-05	0.000375	CcSEcCtD
Irinotecan—Hyponatraemia—Doxorubicin—kidney cancer	2.2e-05	0.000374	CcSEcCtD
Irinotecan—Insomnia—Gemcitabine—kidney cancer	2.2e-05	0.000374	CcSEcCtD
Irinotecan—Headache—Erlotinib—kidney cancer	2.19e-05	0.000373	CcSEcCtD
Irinotecan—Loss of consciousness—Paclitaxel—kidney cancer	2.19e-05	0.000373	CcSEcCtD
Irinotecan—Pain—Vincristine—kidney cancer	2.19e-05	0.000373	CcSEcCtD
Irinotecan—Constipation—Vincristine—kidney cancer	2.19e-05	0.000373	CcSEcCtD
Irinotecan—Osteoarthritis—Doxorubicin—kidney cancer	2.19e-05	0.000373	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	2.19e-05	0.000373	CcSEcCtD
Irinotecan—Paraesthesia—Gemcitabine—kidney cancer	2.18e-05	0.000371	CcSEcCtD
Irinotecan—Flushing—Capecitabine—kidney cancer	2.18e-05	0.000371	CcSEcCtD
Irinotecan—Cardiac disorder—Capecitabine—kidney cancer	2.18e-05	0.000371	CcSEcCtD
Irinotecan—Cough—Paclitaxel—kidney cancer	2.17e-05	0.00037	CcSEcCtD
Irinotecan—Asthenia—Sunitinib—kidney cancer	2.17e-05	0.00037	CcSEcCtD
Irinotecan—Dyspnoea—Gemcitabine—kidney cancer	2.16e-05	0.000369	CcSEcCtD
Irinotecan—Nausea—Vinblastine—kidney cancer	2.16e-05	0.000368	CcSEcCtD
Irinotecan—Somnolence—Gemcitabine—kidney cancer	2.16e-05	0.000367	CcSEcCtD
Irinotecan—Nausea—Everolimus—kidney cancer	2.15e-05	0.000366	CcSEcCtD
Irinotecan—Diarrhoea—Sorafenib—kidney cancer	2.15e-05	0.000366	CcSEcCtD
Irinotecan—Hypertension—Paclitaxel—kidney cancer	2.15e-05	0.000366	CcSEcCtD
Irinotecan—Angiopathy—Capecitabine—kidney cancer	2.13e-05	0.000363	CcSEcCtD
Irinotecan—Immune system disorder—Capecitabine—kidney cancer	2.12e-05	0.000361	CcSEcCtD
Irinotecan—Mediastinal disorder—Capecitabine—kidney cancer	2.12e-05	0.00036	CcSEcCtD
Irinotecan—Decreased appetite—Gemcitabine—kidney cancer	2.11e-05	0.000359	CcSEcCtD
Irinotecan—Hypersensitivity—Dactinomycin—kidney cancer	2.11e-05	0.000359	CcSEcCtD
Irinotecan—Chills—Capecitabine—kidney cancer	2.11e-05	0.000359	CcSEcCtD
Irinotecan—Arrhythmia—Capecitabine—kidney cancer	2.1e-05	0.000357	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Gemcitabine—kidney cancer	2.1e-05	0.000357	CcSEcCtD
Irinotecan—Discomfort—Paclitaxel—kidney cancer	2.09e-05	0.000357	CcSEcCtD
Irinotecan—Fatigue—Gemcitabine—kidney cancer	2.09e-05	0.000356	CcSEcCtD
Irinotecan—Gastrointestinal pain—Vincristine—kidney cancer	2.09e-05	0.000356	CcSEcCtD
Irinotecan—Cardiac arrest—Doxorubicin—kidney cancer	2.08e-05	0.000354	CcSEcCtD
Irinotecan—Dizziness—Sorafenib—kidney cancer	2.08e-05	0.000354	CcSEcCtD
Irinotecan—Constipation—Gemcitabine—kidney cancer	2.08e-05	0.000353	CcSEcCtD
Irinotecan—Pain—Gemcitabine—kidney cancer	2.08e-05	0.000353	CcSEcCtD
Irinotecan—Nausea—Erlotinib—kidney cancer	2.08e-05	0.000353	CcSEcCtD
Irinotecan—Alopecia—Capecitabine—kidney cancer	2.07e-05	0.000353	CcSEcCtD
Irinotecan—Diarrhoea—Sunitinib—kidney cancer	2.07e-05	0.000352	CcSEcCtD
Irinotecan—Asthenia—Dactinomycin—kidney cancer	2.06e-05	0.00035	CcSEcCtD
Irinotecan—Confusional state—Paclitaxel—kidney cancer	2.05e-05	0.000349	CcSEcCtD
Irinotecan—Blood creatinine increased—Doxorubicin—kidney cancer	2.05e-05	0.000349	CcSEcCtD
Irinotecan—Dehydration—Doxorubicin—kidney cancer	2.03e-05	0.000346	CcSEcCtD
Irinotecan—Oedema—Paclitaxel—kidney cancer	2.03e-05	0.000346	CcSEcCtD
Irinotecan—Anaphylactic shock—Paclitaxel—kidney cancer	2.03e-05	0.000346	CcSEcCtD
Irinotecan—Body temperature increased—Vincristine—kidney cancer	2.02e-05	0.000344	CcSEcCtD
Irinotecan—Abdominal pain—Vincristine—kidney cancer	2.02e-05	0.000344	CcSEcCtD
Irinotecan—Infection—Paclitaxel—kidney cancer	2.02e-05	0.000344	CcSEcCtD
Irinotecan—Flatulence—Capecitabine—kidney cancer	2.01e-05	0.000343	CcSEcCtD
Irinotecan—Dizziness—Sunitinib—kidney cancer	2e-05	0.000341	CcSEcCtD
Irinotecan—Feeling abnormal—Gemcitabine—kidney cancer	2e-05	0.000341	CcSEcCtD
Irinotecan—Shock—Paclitaxel—kidney cancer	2e-05	0.000341	CcSEcCtD
Irinotecan—Vomiting—Sorafenib—kidney cancer	2e-05	0.00034	CcSEcCtD
Irinotecan—Orthostatic hypotension—Doxorubicin—kidney cancer	2e-05	0.00034	CcSEcCtD
Irinotecan—Nervous system disorder—Paclitaxel—kidney cancer	1.99e-05	0.000339	CcSEcCtD
Irinotecan—Hypokalaemia—Doxorubicin—kidney cancer	1.99e-05	0.000339	CcSEcCtD
Irinotecan—Thrombocytopenia—Paclitaxel—kidney cancer	1.99e-05	0.000339	CcSEcCtD
Irinotecan—Rash—Sorafenib—kidney cancer	1.98e-05	0.000338	CcSEcCtD
Irinotecan—Dermatitis—Sorafenib—kidney cancer	1.98e-05	0.000337	CcSEcCtD
Irinotecan—Back pain—Capecitabine—kidney cancer	1.98e-05	0.000337	CcSEcCtD
Irinotecan—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	1.97e-05	0.000335	CcSEcCtD
Irinotecan—Headache—Sorafenib—kidney cancer	1.97e-05	0.000335	CcSEcCtD
Irinotecan—Muscle spasms—Capecitabine—kidney cancer	1.97e-05	0.000335	CcSEcCtD
Irinotecan—Hyperhidrosis—Paclitaxel—kidney cancer	1.97e-05	0.000335	CcSEcCtD
Irinotecan—Diarrhoea—Dactinomycin—kidney cancer	1.96e-05	0.000334	CcSEcCtD
Irinotecan—Anorexia—Paclitaxel—kidney cancer	1.94e-05	0.00033	CcSEcCtD
Irinotecan—Vomiting—Sunitinib—kidney cancer	1.92e-05	0.000328	CcSEcCtD
Irinotecan—Body temperature increased—Gemcitabine—kidney cancer	1.92e-05	0.000327	CcSEcCtD
Irinotecan—Rash—Sunitinib—kidney cancer	1.91e-05	0.000325	CcSEcCtD
Irinotecan—Dermatitis—Sunitinib—kidney cancer	1.91e-05	0.000325	CcSEcCtD
Irinotecan—Abdominal distension—Doxorubicin—kidney cancer	1.9e-05	0.000324	CcSEcCtD
Irinotecan—Hypotension—Paclitaxel—kidney cancer	1.9e-05	0.000323	CcSEcCtD
Irinotecan—Ill-defined disorder—Capecitabine—kidney cancer	1.9e-05	0.000323	CcSEcCtD
Irinotecan—Headache—Sunitinib—kidney cancer	1.9e-05	0.000323	CcSEcCtD
Irinotecan—Anaemia—Capecitabine—kidney cancer	1.89e-05	0.000322	CcSEcCtD
Irinotecan—Hypersensitivity—Vincristine—kidney cancer	1.89e-05	0.000321	CcSEcCtD
Irinotecan—Nausea—Sorafenib—kidney cancer	1.87e-05	0.000318	CcSEcCtD
Irinotecan—Pancreatitis—Doxorubicin—kidney cancer	1.85e-05	0.000316	CcSEcCtD
Irinotecan—Malaise—Capecitabine—kidney cancer	1.84e-05	0.000314	CcSEcCtD
Irinotecan—Angina pectoris—Doxorubicin—kidney cancer	1.84e-05	0.000314	CcSEcCtD
Irinotecan—Insomnia—Paclitaxel—kidney cancer	1.84e-05	0.000313	CcSEcCtD
Irinotecan—Vertigo—Capecitabine—kidney cancer	1.84e-05	0.000313	CcSEcCtD
Irinotecan—Asthenia—Vincristine—kidney cancer	1.84e-05	0.000313	CcSEcCtD
Irinotecan—Syncope—Capecitabine—kidney cancer	1.83e-05	0.000312	CcSEcCtD
Irinotecan—Leukopenia—Capecitabine—kidney cancer	1.83e-05	0.000312	CcSEcCtD
Irinotecan—Paraesthesia—Paclitaxel—kidney cancer	1.83e-05	0.000311	CcSEcCtD
Irinotecan—Vomiting—Dactinomycin—kidney cancer	1.82e-05	0.00031	CcSEcCtD
Irinotecan—Dyspnoea—Paclitaxel—kidney cancer	1.81e-05	0.000309	CcSEcCtD
Irinotecan—Somnolence—Paclitaxel—kidney cancer	1.81e-05	0.000308	CcSEcCtD
Irinotecan—Rash—Dactinomycin—kidney cancer	1.81e-05	0.000308	CcSEcCtD
Irinotecan—Nausea—Sunitinib—kidney cancer	1.8e-05	0.000306	CcSEcCtD
Irinotecan—Loss of consciousness—Capecitabine—kidney cancer	1.8e-05	0.000306	CcSEcCtD
Irinotecan—Dyspepsia—Paclitaxel—kidney cancer	1.79e-05	0.000305	CcSEcCtD
Irinotecan—Cough—Capecitabine—kidney cancer	1.78e-05	0.000304	CcSEcCtD
Irinotecan—Neutropenia—Doxorubicin—kidney cancer	1.77e-05	0.000301	CcSEcCtD
Irinotecan—Decreased appetite—Paclitaxel—kidney cancer	1.77e-05	0.000301	CcSEcCtD
Irinotecan—Hypertension—Capecitabine—kidney cancer	1.76e-05	0.0003	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Doxorubicin—kidney cancer	1.76e-05	0.000299	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Paclitaxel—kidney cancer	1.75e-05	0.000299	CcSEcCtD
Irinotecan—Fatigue—Paclitaxel—kidney cancer	1.75e-05	0.000298	CcSEcCtD
Irinotecan—Diarrhoea—Vincristine—kidney cancer	1.75e-05	0.000298	CcSEcCtD
Irinotecan—Asthenia—Gemcitabine—kidney cancer	1.74e-05	0.000297	CcSEcCtD
Irinotecan—Constipation—Paclitaxel—kidney cancer	1.74e-05	0.000296	CcSEcCtD
Irinotecan—Pain—Paclitaxel—kidney cancer	1.74e-05	0.000296	CcSEcCtD
Irinotecan—Discomfort—Capecitabine—kidney cancer	1.72e-05	0.000293	CcSEcCtD
Irinotecan—Weight decreased—Doxorubicin—kidney cancer	1.71e-05	0.000291	CcSEcCtD
Irinotecan—Nausea—Dactinomycin—kidney cancer	1.7e-05	0.00029	CcSEcCtD
Irinotecan—Pneumonia—Doxorubicin—kidney cancer	1.7e-05	0.000289	CcSEcCtD
Irinotecan—Dizziness—Vincristine—kidney cancer	1.69e-05	0.000288	CcSEcCtD
Irinotecan—Confusional state—Capecitabine—kidney cancer	1.68e-05	0.000286	CcSEcCtD
Irinotecan—Feeling abnormal—Paclitaxel—kidney cancer	1.68e-05	0.000285	CcSEcCtD
Irinotecan—Oedema—Capecitabine—kidney cancer	1.67e-05	0.000284	CcSEcCtD
Irinotecan—Gastrointestinal pain—Paclitaxel—kidney cancer	1.66e-05	0.000283	CcSEcCtD
Irinotecan—Diarrhoea—Gemcitabine—kidney cancer	1.66e-05	0.000283	CcSEcCtD
Irinotecan—Renal failure—Doxorubicin—kidney cancer	1.66e-05	0.000282	CcSEcCtD
Irinotecan—Infection—Capecitabine—kidney cancer	1.66e-05	0.000282	CcSEcCtD
Irinotecan—Stomatitis—Doxorubicin—kidney cancer	1.64e-05	0.00028	CcSEcCtD
Irinotecan—Jaundice—Doxorubicin—kidney cancer	1.64e-05	0.00028	CcSEcCtD
Irinotecan—Shock—Capecitabine—kidney cancer	1.64e-05	0.000279	CcSEcCtD
Irinotecan—Nervous system disorder—Capecitabine—kidney cancer	1.64e-05	0.000279	CcSEcCtD
Irinotecan—Thrombocytopenia—Capecitabine—kidney cancer	1.63e-05	0.000278	CcSEcCtD
Irinotecan—Vomiting—Vincristine—kidney cancer	1.63e-05	0.000277	CcSEcCtD
Irinotecan—Sweating—Doxorubicin—kidney cancer	1.62e-05	0.000275	CcSEcCtD
Irinotecan—Rash—Vincristine—kidney cancer	1.61e-05	0.000275	CcSEcCtD
Irinotecan—Hyperhidrosis—Capecitabine—kidney cancer	1.61e-05	0.000275	CcSEcCtD
Irinotecan—Dermatitis—Vincristine—kidney cancer	1.61e-05	0.000274	CcSEcCtD
Irinotecan—Abdominal pain—Paclitaxel—kidney cancer	1.61e-05	0.000274	CcSEcCtD
Irinotecan—Body temperature increased—Paclitaxel—kidney cancer	1.61e-05	0.000274	CcSEcCtD
Irinotecan—Headache—Vincristine—kidney cancer	1.6e-05	0.000273	CcSEcCtD
Irinotecan—Anorexia—Capecitabine—kidney cancer	1.59e-05	0.000271	CcSEcCtD
Irinotecan—Hypotension—Capecitabine—kidney cancer	1.56e-05	0.000265	CcSEcCtD
Irinotecan—Vomiting—Gemcitabine—kidney cancer	1.54e-05	0.000263	CcSEcCtD
Irinotecan—Bradycardia—Doxorubicin—kidney cancer	1.54e-05	0.000262	CcSEcCtD
Irinotecan—Rash—Gemcitabine—kidney cancer	1.53e-05	0.000261	CcSEcCtD
Irinotecan—Dermatitis—Gemcitabine—kidney cancer	1.53e-05	0.00026	CcSEcCtD
Irinotecan—Haemoglobin—Doxorubicin—kidney cancer	1.52e-05	0.000259	CcSEcCtD
Irinotecan—Headache—Gemcitabine—kidney cancer	1.52e-05	0.000259	CcSEcCtD
Irinotecan—Nausea—Vincristine—kidney cancer	1.52e-05	0.000259	CcSEcCtD
Irinotecan—Rhinitis—Doxorubicin—kidney cancer	1.52e-05	0.000258	CcSEcCtD
Irinotecan—Haemorrhage—Doxorubicin—kidney cancer	1.51e-05	0.000258	CcSEcCtD
Irinotecan—Insomnia—Capecitabine—kidney cancer	1.51e-05	0.000257	CcSEcCtD
Irinotecan—Paraesthesia—Capecitabine—kidney cancer	1.5e-05	0.000255	CcSEcCtD
Irinotecan—Hypersensitivity—Paclitaxel—kidney cancer	1.5e-05	0.000255	CcSEcCtD
Irinotecan—Connective tissue disorder—Doxorubicin—kidney cancer	1.49e-05	0.000253	CcSEcCtD
Irinotecan—Dyspnoea—Capecitabine—kidney cancer	1.49e-05	0.000253	CcSEcCtD
Irinotecan—Dyspepsia—Capecitabine—kidney cancer	1.47e-05	0.00025	CcSEcCtD
Irinotecan—Visual impairment—Doxorubicin—kidney cancer	1.46e-05	0.000248	CcSEcCtD
Irinotecan—Asthenia—Paclitaxel—kidney cancer	1.46e-05	0.000248	CcSEcCtD
Irinotecan—Decreased appetite—Capecitabine—kidney cancer	1.45e-05	0.000247	CcSEcCtD
Irinotecan—Nausea—Gemcitabine—kidney cancer	1.44e-05	0.000246	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Capecitabine—kidney cancer	1.44e-05	0.000245	CcSEcCtD
Irinotecan—Fatigue—Capecitabine—kidney cancer	1.44e-05	0.000245	CcSEcCtD
Irinotecan—Constipation—Capecitabine—kidney cancer	1.43e-05	0.000243	CcSEcCtD
Irinotecan—Pain—Capecitabine—kidney cancer	1.43e-05	0.000243	CcSEcCtD
Irinotecan—Cardiac disorder—Doxorubicin—kidney cancer	1.4e-05	0.000239	CcSEcCtD
Irinotecan—Flushing—Doxorubicin—kidney cancer	1.4e-05	0.000239	CcSEcCtD
Irinotecan—Diarrhoea—Paclitaxel—kidney cancer	1.39e-05	0.000237	CcSEcCtD
Irinotecan—Feeling abnormal—Capecitabine—kidney cancer	1.37e-05	0.000234	CcSEcCtD
Irinotecan—Angiopathy—Doxorubicin—kidney cancer	1.37e-05	0.000234	CcSEcCtD
Irinotecan—Immune system disorder—Doxorubicin—kidney cancer	1.37e-05	0.000233	CcSEcCtD
Irinotecan—Gastrointestinal pain—Capecitabine—kidney cancer	1.36e-05	0.000232	CcSEcCtD
Irinotecan—Mediastinal disorder—Doxorubicin—kidney cancer	1.36e-05	0.000232	CcSEcCtD
Irinotecan—Chills—Doxorubicin—kidney cancer	1.36e-05	0.000231	CcSEcCtD
Irinotecan—Arrhythmia—Doxorubicin—kidney cancer	1.35e-05	0.00023	CcSEcCtD
Irinotecan—Dizziness—Paclitaxel—kidney cancer	1.34e-05	0.000229	CcSEcCtD
Irinotecan—Alopecia—Doxorubicin—kidney cancer	1.34e-05	0.000228	CcSEcCtD
Irinotecan—Body temperature increased—Capecitabine—kidney cancer	1.32e-05	0.000225	CcSEcCtD
Irinotecan—Abdominal pain—Capecitabine—kidney cancer	1.32e-05	0.000225	CcSEcCtD
Irinotecan—Flatulence—Doxorubicin—kidney cancer	1.3e-05	0.000221	CcSEcCtD
Irinotecan—Vomiting—Paclitaxel—kidney cancer	1.29e-05	0.00022	CcSEcCtD
Irinotecan—Rash—Paclitaxel—kidney cancer	1.28e-05	0.000218	CcSEcCtD
Irinotecan—Dermatitis—Paclitaxel—kidney cancer	1.28e-05	0.000218	CcSEcCtD
Irinotecan—Back pain—Doxorubicin—kidney cancer	1.27e-05	0.000217	CcSEcCtD
Irinotecan—Headache—Paclitaxel—kidney cancer	1.27e-05	0.000217	CcSEcCtD
Irinotecan—Muscle spasms—Doxorubicin—kidney cancer	1.27e-05	0.000216	CcSEcCtD
Irinotecan—Hypersensitivity—Capecitabine—kidney cancer	1.23e-05	0.000209	CcSEcCtD
Irinotecan—Ill-defined disorder—Doxorubicin—kidney cancer	1.22e-05	0.000208	CcSEcCtD
Irinotecan—Anaemia—Doxorubicin—kidney cancer	1.22e-05	0.000207	CcSEcCtD
Irinotecan—Nausea—Paclitaxel—kidney cancer	1.21e-05	0.000206	CcSEcCtD
Irinotecan—Asthenia—Capecitabine—kidney cancer	1.2e-05	0.000204	CcSEcCtD
Irinotecan—Malaise—Doxorubicin—kidney cancer	1.19e-05	0.000202	CcSEcCtD
Irinotecan—Vertigo—Doxorubicin—kidney cancer	1.18e-05	0.000202	CcSEcCtD
Irinotecan—Syncope—Doxorubicin—kidney cancer	1.18e-05	0.000201	CcSEcCtD
Irinotecan—Leukopenia—Doxorubicin—kidney cancer	1.18e-05	0.000201	CcSEcCtD
Irinotecan—Loss of consciousness—Doxorubicin—kidney cancer	1.16e-05	0.000197	CcSEcCtD
Irinotecan—Cough—Doxorubicin—kidney cancer	1.15e-05	0.000196	CcSEcCtD
Irinotecan—Diarrhoea—Capecitabine—kidney cancer	1.14e-05	0.000194	CcSEcCtD
Irinotecan—Hypertension—Doxorubicin—kidney cancer	1.14e-05	0.000194	CcSEcCtD
Irinotecan—Discomfort—Doxorubicin—kidney cancer	1.11e-05	0.000189	CcSEcCtD
Irinotecan—Dizziness—Capecitabine—kidney cancer	1.1e-05	0.000188	CcSEcCtD
Irinotecan—Confusional state—Doxorubicin—kidney cancer	1.08e-05	0.000185	CcSEcCtD
Irinotecan—Anaphylactic shock—Doxorubicin—kidney cancer	1.08e-05	0.000183	CcSEcCtD
Irinotecan—Oedema—Doxorubicin—kidney cancer	1.08e-05	0.000183	CcSEcCtD
Irinotecan—Infection—Doxorubicin—kidney cancer	1.07e-05	0.000182	CcSEcCtD
Irinotecan—Vomiting—Capecitabine—kidney cancer	1.06e-05	0.000181	CcSEcCtD
Irinotecan—Shock—Doxorubicin—kidney cancer	1.06e-05	0.00018	CcSEcCtD
Irinotecan—Nervous system disorder—Doxorubicin—kidney cancer	1.05e-05	0.00018	CcSEcCtD
Irinotecan—Thrombocytopenia—Doxorubicin—kidney cancer	1.05e-05	0.000179	CcSEcCtD
Irinotecan—Rash—Capecitabine—kidney cancer	1.05e-05	0.000179	CcSEcCtD
Irinotecan—Dermatitis—Capecitabine—kidney cancer	1.05e-05	0.000179	CcSEcCtD
Irinotecan—Headache—Capecitabine—kidney cancer	1.04e-05	0.000178	CcSEcCtD
Irinotecan—Hyperhidrosis—Doxorubicin—kidney cancer	1.04e-05	0.000177	CcSEcCtD
Irinotecan—Anorexia—Doxorubicin—kidney cancer	1.02e-05	0.000175	CcSEcCtD
Irinotecan—Hypotension—Doxorubicin—kidney cancer	1e-05	0.000171	CcSEcCtD
Irinotecan—Nausea—Capecitabine—kidney cancer	9.91e-06	0.000169	CcSEcCtD
Irinotecan—Insomnia—Doxorubicin—kidney cancer	9.73e-06	0.000166	CcSEcCtD
Irinotecan—Paraesthesia—Doxorubicin—kidney cancer	9.66e-06	0.000164	CcSEcCtD
Irinotecan—Dyspnoea—Doxorubicin—kidney cancer	9.59e-06	0.000163	CcSEcCtD
Irinotecan—Somnolence—Doxorubicin—kidney cancer	9.56e-06	0.000163	CcSEcCtD
Irinotecan—Dyspepsia—Doxorubicin—kidney cancer	9.46e-06	0.000161	CcSEcCtD
Irinotecan—Decreased appetite—Doxorubicin—kidney cancer	9.35e-06	0.000159	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Doxorubicin—kidney cancer	9.28e-06	0.000158	CcSEcCtD
Irinotecan—Fatigue—Doxorubicin—kidney cancer	9.27e-06	0.000158	CcSEcCtD
Irinotecan—Pain—Doxorubicin—kidney cancer	9.19e-06	0.000157	CcSEcCtD
Irinotecan—Constipation—Doxorubicin—kidney cancer	9.19e-06	0.000157	CcSEcCtD
Irinotecan—Feeling abnormal—Doxorubicin—kidney cancer	8.86e-06	0.000151	CcSEcCtD
Irinotecan—Gastrointestinal pain—Doxorubicin—kidney cancer	8.79e-06	0.00015	CcSEcCtD
Irinotecan—Abdominal pain—Doxorubicin—kidney cancer	8.5e-06	0.000145	CcSEcCtD
Irinotecan—Body temperature increased—Doxorubicin—kidney cancer	8.5e-06	0.000145	CcSEcCtD
Irinotecan—Hypersensitivity—Doxorubicin—kidney cancer	7.92e-06	0.000135	CcSEcCtD
Irinotecan—Asthenia—Doxorubicin—kidney cancer	7.71e-06	0.000131	CcSEcCtD
Irinotecan—Diarrhoea—Doxorubicin—kidney cancer	7.36e-06	0.000125	CcSEcCtD
Irinotecan—Dizziness—Doxorubicin—kidney cancer	7.11e-06	0.000121	CcSEcCtD
Irinotecan—Vomiting—Doxorubicin—kidney cancer	6.84e-06	0.000116	CcSEcCtD
Irinotecan—Rash—Doxorubicin—kidney cancer	6.78e-06	0.000115	CcSEcCtD
Irinotecan—Dermatitis—Doxorubicin—kidney cancer	6.77e-06	0.000115	CcSEcCtD
Irinotecan—Headache—Doxorubicin—kidney cancer	6.74e-06	0.000115	CcSEcCtD
Irinotecan—Nausea—Doxorubicin—kidney cancer	6.39e-06	0.000109	CcSEcCtD
Irinotecan—ABCC1—Disease—CDKN2B—kidney cancer	2.79e-06	0.000117	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PSMD7—kidney cancer	2.79e-06	0.000117	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.79e-06	0.000117	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.76e-06	0.000116	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—SLC2A1—kidney cancer	2.75e-06	0.000115	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.74e-06	0.000115	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SLC5A3—kidney cancer	2.7e-06	0.000113	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PGK1—kidney cancer	2.7e-06	0.000113	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PDHB—kidney cancer	2.7e-06	0.000113	CbGpPWpGaD
Irinotecan—CYP3A4—Biological oxidations—POMC—kidney cancer	2.69e-06	0.000112	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.68e-06	0.000112	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—BCHE—kidney cancer	2.67e-06	0.000112	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.67e-06	0.000112	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—LDHB—kidney cancer	2.65e-06	0.000111	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CRABP1—kidney cancer	2.65e-06	0.000111	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.65e-06	0.000111	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—BCHE—kidney cancer	2.65e-06	0.000111	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—GSTP1—kidney cancer	2.64e-06	0.00011	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—SLC5A5—kidney cancer	2.64e-06	0.00011	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CA9—kidney cancer	2.62e-06	0.00011	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.62e-06	0.00011	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—SLC5A5—kidney cancer	2.61e-06	0.000109	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CRABP1—kidney cancer	2.59e-06	0.000108	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.56e-06	0.000107	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	2.56e-06	0.000107	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—SLC2A1—kidney cancer	2.55e-06	0.000107	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.54e-06	0.000106	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CCBL1—kidney cancer	2.53e-06	0.000106	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—SLC2A1—kidney cancer	2.52e-06	0.000106	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.52e-06	0.000105	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—GSTP1—kidney cancer	2.5e-06	0.000105	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—GSTP1—kidney cancer	2.5e-06	0.000105	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—ABCB1—kidney cancer	2.5e-06	0.000105	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ITPR2—kidney cancer	2.46e-06	0.000103	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.45e-06	0.000103	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.43e-06	0.000102	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—GSTM1—kidney cancer	2.42e-06	0.000101	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	2.42e-06	0.000101	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—GSTP1—kidney cancer	2.41e-06	0.000101	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ITPR2—kidney cancer	2.41e-06	0.000101	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.39e-06	0.0001	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.38e-06	9.98e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—CTNNB1—kidney cancer	2.37e-06	9.93e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ABCB1—kidney cancer	2.37e-06	9.92e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ABCB1—kidney cancer	2.37e-06	9.92e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—GSTP1—kidney cancer	2.35e-06	9.85e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.33e-06	9.74e-05	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.32e-06	9.71e-05	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	2.3e-06	9.64e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—GSTM1—kidney cancer	2.3e-06	9.63e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—GSTM1—kidney cancer	2.3e-06	9.63e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CYP1A1—kidney cancer	2.3e-06	9.62e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CA9—kidney cancer	2.3e-06	9.62e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—GSTP1—kidney cancer	2.29e-06	9.6e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ABCB1—kidney cancer	2.29e-06	9.57e-05	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.27e-06	9.5e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GSTT1—kidney cancer	2.25e-06	9.4e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ACHE—kidney cancer	2.25e-06	9.4e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HIF1A—kidney cancer	2.23e-06	9.35e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CRABP1—kidney cancer	2.23e-06	9.34e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ABCB1—kidney cancer	2.23e-06	9.33e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—TSC2—kidney cancer	2.23e-06	9.32e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—GSTM1—kidney cancer	2.22e-06	9.29e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.2e-06	9.2e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PPAT—kidney cancer	2.2e-06	9.2e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GSTT1—kidney cancer	2.2e-06	9.19e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ACHE—kidney cancer	2.2e-06	9.19e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CYP1A1—kidney cancer	2.18e-06	9.13e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CYP1A1—kidney cancer	2.18e-06	9.13e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—POMC—kidney cancer	2.18e-06	9.11e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ABCB1—kidney cancer	2.17e-06	9.09e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—GSTM1—kidney cancer	2.16e-06	9.05e-05	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.14e-06	8.97e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—SCARB1—kidney cancer	2.13e-06	8.9e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GSTP1—kidney cancer	2.12e-06	8.89e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—CTNNB1—kidney cancer	2.12e-06	8.86e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—GSTM1—kidney cancer	2.11e-06	8.82e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GSTP1—kidney cancer	2.11e-06	8.81e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTGS1—kidney cancer	2.1e-06	8.81e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CYP1A1—kidney cancer	2.1e-06	8.8e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—SCARB1—kidney cancer	2.08e-06	8.7e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ITPR2—kidney cancer	2.07e-06	8.68e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PSMD7—kidney cancer	2.06e-06	8.64e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTGS1—kidney cancer	2.06e-06	8.61e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CYP1A1—kidney cancer	2.05e-06	8.58e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—FH—kidney cancer	2.04e-06	8.55e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—APRT—kidney cancer	2.04e-06	8.55e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PSMD7—kidney cancer	2.02e-06	8.45e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ABCB1—kidney cancer	2.01e-06	8.42e-05	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	2e-06	8.37e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CYP1A1—kidney cancer	2e-06	8.37e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ABCB1—kidney cancer	1.99e-06	8.34e-05	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.97e-06	8.24e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—APC—kidney cancer	1.97e-06	8.23e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—KIT—kidney cancer	1.97e-06	8.23e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—BCHE—kidney cancer	1.96e-06	8.19e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CRABP1—kidney cancer	1.95e-06	8.18e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GSTM1—kidney cancer	1.95e-06	8.17e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GSTM1—kidney cancer	1.93e-06	8.1e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—SLC5A5—kidney cancer	1.93e-06	8.09e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GPC3—kidney cancer	1.92e-06	8.04e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—BCHE—kidney cancer	1.91e-06	8.01e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.91e-06	8e-05	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.9e-06	7.97e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTT1—kidney cancer	1.89e-06	7.92e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ACHE—kidney cancer	1.89e-06	7.92e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—SLC5A5—kidney cancer	1.89e-06	7.91e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.89e-06	7.9e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CA2—kidney cancer	1.87e-06	7.82e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—SLC2A1—kidney cancer	1.87e-06	7.81e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CYP1A1—kidney cancer	1.85e-06	7.75e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—BRAF—kidney cancer	1.85e-06	7.74e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CYP1A1—kidney cancer	1.83e-06	7.68e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—SLC2A1—kidney cancer	1.82e-06	7.64e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALAD—kidney cancer	1.82e-06	7.62e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ITPR2—kidney cancer	1.82e-06	7.61e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.79e-06	7.5e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—SCARB1—kidney cancer	1.79e-06	7.49e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.78e-06	7.44e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTGS1—kidney cancer	1.77e-06	7.42e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PSMD7—kidney cancer	1.74e-06	7.27e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.74e-06	7.27e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PTGS2—kidney cancer	1.74e-06	7.27e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—RAF1—kidney cancer	1.73e-06	7.25e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.73e-06	7.23e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—POMC—kidney cancer	1.71e-06	7.17e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.68e-06	7.05e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PGK1—kidney cancer	1.67e-06	6.97e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.67e-06	6.97e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTT1—kidney cancer	1.66e-06	6.94e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ACHE—kidney cancer	1.66e-06	6.94e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—BCHE—kidney cancer	1.65e-06	6.9e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.64e-06	6.87e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—LDHB—kidney cancer	1.63e-06	6.84e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—SLC5A5—kidney cancer	1.63e-06	6.81e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—POMC—kidney cancer	1.63e-06	6.81e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—POMC—kidney cancer	1.63e-06	6.81e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—SLC2A1—kidney cancer	1.57e-06	6.58e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SCARB1—kidney cancer	1.57e-06	6.57e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—POMC—kidney cancer	1.57e-06	6.56e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GSTP1—kidney cancer	1.56e-06	6.52e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTGS1—kidney cancer	1.55e-06	6.5e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—IL2—kidney cancer	1.55e-06	6.5e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—RAF1—kidney cancer	1.54e-06	6.46e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—POMC—kidney cancer	1.53e-06	6.4e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—ERBB2—kidney cancer	1.53e-06	6.39e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.52e-06	6.38e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PSMD7—kidney cancer	1.52e-06	6.37e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GSTP1—kidney cancer	1.52e-06	6.37e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PTEN—kidney cancer	1.51e-06	6.34e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MTOR—kidney cancer	1.51e-06	6.31e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CD4—kidney cancer	1.5e-06	6.3e-05	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	1.5e-06	6.27e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTGS2—kidney cancer	1.49e-06	6.25e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—POMC—kidney cancer	1.49e-06	6.24e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ABCB1—kidney cancer	1.47e-06	6.17e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—BCHE—kidney cancer	1.44e-06	6.04e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ABCB1—kidney cancer	1.44e-06	6.03e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GSTM1—kidney cancer	1.43e-06	5.99e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SLC5A5—kidney cancer	1.43e-06	5.97e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CA9—kidney cancer	1.42e-06	5.93e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CDKN1B—kidney cancer	1.41e-06	5.92e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GSTM1—kidney cancer	1.4e-06	5.85e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—POMC—kidney cancer	1.38e-06	5.78e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—SLC2A1—kidney cancer	1.38e-06	5.76e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—POMC—kidney cancer	1.37e-06	5.72e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTGS2—kidney cancer	1.37e-06	5.72e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CYP1A1—kidney cancer	1.36e-06	5.68e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CTNNB1—kidney cancer	1.34e-06	5.59e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.33e-06	5.57e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CYP1A1—kidney cancer	1.33e-06	5.55e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—VEGFA—kidney cancer	1.32e-06	5.52e-05	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.31e-06	5.5e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTP1—kidney cancer	1.31e-06	5.49e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTEN—kidney cancer	1.3e-06	5.45e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTGS2—kidney cancer	1.3e-06	5.43e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTGS2—kidney cancer	1.3e-06	5.43e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTGS2—kidney cancer	1.25e-06	5.24e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—MAPK3—kidney cancer	1.25e-06	5.22e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ABCB1—kidney cancer	1.24e-06	5.19e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTGS2—kidney cancer	1.22e-06	5.1e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTM1—kidney cancer	1.2e-06	5.04e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CRABP1—kidney cancer	1.2e-06	5.04e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTEN—kidney cancer	1.19e-06	4.99e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTGS2—kidney cancer	1.19e-06	4.98e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—MAPK1—kidney cancer	1.19e-06	4.97e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTP1—kidney cancer	1.15e-06	4.81e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP1A1—kidney cancer	1.14e-06	4.78e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTEN—kidney cancer	1.13e-06	4.73e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTEN—kidney cancer	1.13e-06	4.73e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—KRAS—kidney cancer	1.12e-06	4.69e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ITPR2—kidney cancer	1.12e-06	4.69e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MAPK3—kidney cancer	1.11e-06	4.66e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTGS2—kidney cancer	1.1e-06	4.61e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTGS2—kidney cancer	1.09e-06	4.57e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTEN—kidney cancer	1.09e-06	4.57e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MYC—kidney cancer	1.08e-06	4.53e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PIK3CA—kidney cancer	1.07e-06	4.47e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTEN—kidney cancer	1.06e-06	4.45e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MAPK1—kidney cancer	1.06e-06	4.43e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTM1—kidney cancer	1.06e-06	4.42e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTEN—kidney cancer	1.04e-06	4.34e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CA—kidney cancer	1.03e-06	4.31e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTT1—kidney cancer	1.02e-06	4.27e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ACHE—kidney cancer	1.02e-06	4.27e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—POMC—kidney cancer	1.01e-06	4.23e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP1A1—kidney cancer	1e-06	4.19e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—KRAS—kidney cancer	1e-06	4.19e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TP53—kidney cancer	9.97e-07	4.17e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—POMC—kidney cancer	9.88e-07	4.14e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SCARB1—kidney cancer	9.66e-07	4.04e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTEN—kidney cancer	9.6e-07	4.02e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTGS1—kidney cancer	9.57e-07	4e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTEN—kidney cancer	9.51e-07	3.98e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.38e-07	3.93e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PSMD7—kidney cancer	9.38e-07	3.93e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3CA—kidney cancer	9.19e-07	3.85e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—BCHE—kidney cancer	8.89e-07	3.72e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC5A5—kidney cancer	8.78e-07	3.68e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—POMC—kidney cancer	8.51e-07	3.56e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—SLC2A1—kidney cancer	8.48e-07	3.55e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CA—kidney cancer	8.41e-07	3.52e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTGS2—kidney cancer	8.07e-07	3.38e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CA—kidney cancer	7.98e-07	3.34e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CA—kidney cancer	7.98e-07	3.34e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTGS2—kidney cancer	7.88e-07	3.3e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CA—kidney cancer	7.69e-07	3.22e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CA—kidney cancer	7.5e-07	3.14e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—POMC—kidney cancer	7.46e-07	3.12e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CA—kidney cancer	7.31e-07	3.06e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTP1—kidney cancer	7.08e-07	2.96e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTEN—kidney cancer	7.03e-07	2.94e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTEN—kidney cancer	6.88e-07	2.88e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTGS2—kidney cancer	6.79e-07	2.84e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CA—kidney cancer	6.77e-07	2.83e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CA—kidney cancer	6.71e-07	2.81e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ABCB1—kidney cancer	6.7e-07	2.8e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTM1—kidney cancer	6.5e-07	2.72e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP1A1—kidney cancer	6.16e-07	2.58e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTGS2—kidney cancer	5.95e-07	2.49e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTEN—kidney cancer	5.92e-07	2.48e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTEN—kidney cancer	5.19e-07	2.17e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CA—kidney cancer	4.96e-07	2.08e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CA—kidney cancer	4.85e-07	2.03e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—POMC—kidney cancer	4.6e-07	1.92e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CA—kidney cancer	4.18e-07	1.75e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTGS2—kidney cancer	3.67e-07	1.53e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CA—kidney cancer	3.66e-07	1.53e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTEN—kidney cancer	3.2e-07	1.34e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.26e-07	9.44e-06	CbGpPWpGaD
